Know Cancer

or
forgot password

    • cancer clinical trials in maumee, OH

    • Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Breast Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Northwest Ohio Oncology Center
    Maumee, Ohio 43537
    Breast Cancer
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Northwest Ohio Oncology Center

    Trial Locations
    Northwest Ohio Oncology Center
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Endometrial Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Kidney Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Northwest Ohio Oncology Center

    Trial Locations
    Northwest Ohio Oncology Center
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Northwest Ohio Oncology Center

    Trial Locations
    Northwest Ohio Oncology Center
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Recurrent Mantle Cell Lymphoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Luke's Hospital

    Trial Locations
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Toledo Clinic Cancer Centers-Maumee
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Maumee, Ohio 43537
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Toledo Clinic Cancer Centers-Maumee
    Maumee, Ohio 43537-1839
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    St. Luke's Hospital

    Trial Locations
    St. Luke's Hospital
    Northwest Ohio Oncology Center
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center

    Trial Locations
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Toledo Clinic Cancer Centers-Maumee
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Toledo Clinic Cancer Centers-Maumee
    Maumee, Ohio 43537-1839
    Gastrointestinal Stromal Tumor
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint Luke's Hospital

    Trial Locations
    Saint Luke's Hospital
    Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer